US medical devices industry saw a drop of 25% in overall deal activity during June 2022, when compared with the last 12-month average, led by Evolent Health’s $462m acquisition of Implantable Provider Group, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

A total of 81 deals worth $1.6bn were announced in June 2022, compared with the 12-month average of 108 deals.

venture financing was the leading category in the month in terms of volume with 57 deals, which accounted for 70.4% of all deals.

In second place was M&A with 17 deals, followed by private equity with seven transactions, respectively accounting for 21% and 8.6% of overall deal activity in the US technology industry during the month.

In terms of value of deals, venture financing was the leading deal category in the US medical devices industry with total deals worth $767.6m, while M&A and private equity deals totalled $702.1m and $129.1m, respectively.

US medical devices industry deals in June 2022: Top deals

The top five medical devices industry deals accounted for 53.8% of the overall value during June 2022.

The combined value of the top five medical devices deals stood at $859.8m, against the overall value of $1.6bn recorded for the month.

The top five medical devices industry deals of June 2022 tracked by GlobalData were:

1) Evolent Health $462m acquisition deal with Implantable Provider Group

2) The $177.8m acquisition of Guardant Health AMEA by Guardant Health

3) Patient Square Capital $100m private equity deal with Eargo

4) The $60m venture financing of Aerin Medical by Ally Bridge Group,KCK Group,Orbimed Advisors and Questa Capital Management

5) Amplify Partners,B Capital Group and Felicis Ventures $60m venture financing deal with Mission Health Labs